57 related articles for article (PubMed ID: 21151099)
1. VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
von Teichman A; Compérat E; Behnke S; Storz M; Moch H; Schraml P
Mod Pathol; 2011 Apr; 24(4):571-8. PubMed ID: 21151099
[TBL] [Abstract][Full Text] [Related]
2. Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance.
Razafinjatovo C; Bihr S; Mischo A; Vogl U; Schmidinger M; Moch H; Schraml P
BMC Cancer; 2016 Aug; 16():638. PubMed ID: 27530247
[TBL] [Abstract][Full Text] [Related]
3. Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen.
Bommi-Reddy A; Almeciga I; Sawyer J; Geisen C; Li W; Harlow E; Kaelin WG; Grueneberg DA
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16484-9. PubMed ID: 18948595
[TBL] [Abstract][Full Text] [Related]
4. Renal Neuroendocrine Tumor: A Case Report with Evaluation of Grading Criteria and Relationship with Carbonic Anhydrase 9 Immunoreactivity.
Monroe HL; Patadji Santiago S; Williams HJ; El Naili R
Int J Surg Pathol; 2024 May; 32(3):570-577. PubMed ID: 37461831
[TBL] [Abstract][Full Text] [Related]
5. Multilocular cystic renal cell carcinoma in a 23 year old female.
Udasimath S; Niranjan J; Puruhotham R; Nagesha KR
Urol Ann; 2016; 8(4):506-508. PubMed ID: 28058005
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease and multilocular cystic renal neoplasm of low malignant potential: An unusual association.
Soumaya M; Mehdi K; Nadia M; Tahar Y; Nour E; Slama Ayda B; Ali J
Urol Case Rep; 2018 Jan; 16():79-80. PubMed ID: 29204358
[No Abstract] [Full Text] [Related]
7. Philadelphia Hospital, Service of Meredith Clymer, M. D. Case of Soft Cancer of the Ovary, with a Multilocular Cystic Dropsy.
Benedict WC
Med Exam (Phila); 1843 Jul; 6(13):148-149. PubMed ID: 38119875
[No Abstract] [Full Text] [Related]
8. Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Lee KH; Park WS; Chung J
Histol Histopathol; 2018 Jun; 33(6):589-596. PubMed ID: 29292824
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney.
Sadimin ET; Chen YB; Wang L; Argani P; Epstein JI
Histopathology; 2017 Nov; 71(5):719-724. PubMed ID: 28656700
[TBL] [Abstract][Full Text] [Related]
10. Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.
Stampone E; Bencivenga D; Capellupo MC; Roberti D; Tartaglione I; Perrotta S; Della Ragione F; Borriello A
Cell Mol Life Sci; 2023 Jul; 80(8):220. PubMed ID: 37477829
[TBL] [Abstract][Full Text] [Related]
11. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.
Yang B; Sun L; Cao WF; Qi LS; Guo YH; Sun Y
Diagn Pathol; 2023 Feb; 18(1):27. PubMed ID: 36810118
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma.
Novacescu D; Feciche BO; Cumpanas AA; Bardan R; Rusmir AV; Bitar YA; Barbos VI; Cut TG; Raica M; Latcu SC
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428491
[TBL] [Abstract][Full Text] [Related]
13. Comparison of survival between unilocular cystic and purely solid renal cell carcinoma.
Wang Y; Niu X; Wang L; Li Y; Qiao B
Sci Rep; 2022 Jul; 12(1):12865. PubMed ID: 35896562
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist's Perspective.
Pitra T; Pivovarcikova K; Alaghehbandan R; Bartos Vesela A; Tupy R; Hora M; Hes O
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159098
[TBL] [Abstract][Full Text] [Related]
15. Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach.
Alaghehbandan R; Perez Montiel D; Luis AS; Hes O
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31905821
[TBL] [Abstract][Full Text] [Related]
16.
Kim SH; Park WS; Chung J
Investig Clin Urol; 2019 May; 60(3):148-155. PubMed ID: 31098421
[TBL] [Abstract][Full Text] [Related]
17. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
Tretiakova M; Mehta V; Kocherginsky M; Minor A; Shen SS; Sirintrapun SJ; Yao JL; Alvarado-Cabrero I; Antic T; Eggener SE; Picken MM; Paner GP
Virchows Arch; 2018 Jul; 473(1):85-93. PubMed ID: 29770853
[TBL] [Abstract][Full Text] [Related]
18. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
Inamura K
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: the search for a reliable biomarker.
Farber NJ; Kim CJ; Modi PK; Hon JD; Sadimin ET; Singer EA
Transl Cancer Res; 2017 Jun; 6(3):620-632. PubMed ID: 28775935
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
